The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology.
Haverkamp, W
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. [electronic resource] - Cardiovascular research Aug 2000 - 219-33 p. digital
Publication Type: Congress; Research Support, Non-U.S. Gov't
0008-6363
10.1016/s0008-6363(00)00119-x doi
Action Potentials--drug effects
Animals
Anti-Arrhythmia Agents--adverse effects
Anti-Bacterial Agents--adverse effects
Antipsychotic Agents--adverse effects
Cardiology
Clinical Trials as Topic
Disease Models, Animal
Drug and Narcotic Control
Europe
Humans
Potassium Channels--drug effects
Product Surveillance, Postmarketing
Research
Societies, Medical
Torsades de Pointes--chemically induced
Vasodilator Agents--adverse effects
The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. [electronic resource] - Cardiovascular research Aug 2000 - 219-33 p. digital
Publication Type: Congress; Research Support, Non-U.S. Gov't
0008-6363
10.1016/s0008-6363(00)00119-x doi
Action Potentials--drug effects
Animals
Anti-Arrhythmia Agents--adverse effects
Anti-Bacterial Agents--adverse effects
Antipsychotic Agents--adverse effects
Cardiology
Clinical Trials as Topic
Disease Models, Animal
Drug and Narcotic Control
Europe
Humans
Potassium Channels--drug effects
Product Surveillance, Postmarketing
Research
Societies, Medical
Torsades de Pointes--chemically induced
Vasodilator Agents--adverse effects